Filing Details

Accession Number:
0001209191-22-047741
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-26 17:33:42
Reporting Period:
2022-08-26
Accepted Time:
2022-08-26 17:33:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850261 Sorrento Therapeutics Inc. SRNE Biological Products, (No Disgnostic Substances) (2836) 330344842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1470981 Henry Ji C/O Sorrento Therapeutics, Inc.
4955 Directors Place
San Diego CA 92121
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-26 33,333 $2.11 2,121,362 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Put Option (obligation to buy) Disposition 2022-08-26 200 $349.33 20,000 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200 2022-08-26 2023-03-17 No 4 S Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,271,693 Indirect See Footnote
Common Stock 40,000 Indirect By spouse
Footnotes
  1. Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.